DCA and Other Promising Cancer Therapies
Many medications have shown promise in the treatment of cancer either in human studies or animal studies. However, these drugs are unlikely to be approved and marketed as cancer treatments because they may be off patent or not patentable. Without a drug patent, it is difficult to find funds for expensive human trials since the cost of the trials could never be recovered.
Some of the drugs we prescribe have not completed the necessary 3 stages of clinical trials, and are therefore considered “unproven” despite the fact that they have shown good results in preliminary cancer research.
We are currently accepting cancer patients (any tumour type) for treatment with these medications who:
- have failed conventional, scientifically proven treatments
- have been told by their doctor that there is no safe or effective treatment for their cancer
- are unable to take conventional treatments due to their age or concurrent medical problems
- have been treated for cancer, and have no proven options to help prevent recurrence
We may prescribe one or more of these medications to our patients since we abide by the strict regulatory requirements for their off-label use.
For some patients, we may suggest combining 2 or more drugs to improve the chances of treatment success. Combinations are chosen based on scientific theory, medical judgment, and favourable clinical experience. Anecdotal efficacy data is available on many combination treatments.